Accordingly, the field is moving away from using these lines, with few exceptions (e.g. the VavP-Bcl2 and Bcl2-Ig mice discussed in the Follicular Lymphoma section) (35, 36). This evidence concerns the gene BCL2 and follicular lymphoma.